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OBJECTIVE
To examine potential relationships between ECG characteristics and 
echocardiographic measures of cardiac structure in chimpanzees (Pan 
troglodytes).
ANIMALS
341 chimpanzees (175 males and 166 females) from 5 sanctuaries and 2 
zoological collections.
PROCEDURES
Chimpanzees were anesthetized for routine health examinations between 
May 2011 and July 2017 as part of the International Primate Heart Proj-
ect and, during the same anesthetic events, underwent 12-lead ECG and 
transthoracic echocardiographic assessments. Relationships between re-
sults for ECG and those for echocardiographic measures of atrial areas, left 
ventricular internal diameter in diastole (LVIDd), and mean left ventricular 
wall thicknesses (MLVWT) were assessed with correlational analysis, then 
multiple linear regression analyses were used to create hierarchical models 
to predict cardiac structure from ECG findings.
RESULTS
Findings indicated correlations (r = –0.231 to 0.310) between results for 
ECG variables and echocardiographic measures. The duration and ampli-
tude of P waves in lead II had the strongest correlations with atrial areas. 
The Sokolow-Lyon criteria, QRS-complex duration, and R-wave amplitude 
in leads V6 and II had the strongest correlations with MLVWT, whereas the 
Sokolow-Lyon criteria, QRS-complex duration, and S-wave amplitude in 
leads V2 and V1 had the strongest correlations with LVIDd. However, the 
ECG predictive models that were generated only accounted for 17%, 7%, 
11%, and 8% of the variance in the right atrial end-systolic area, left atrial 
end-systolic area, MLVWT, and LVIDd, respectively.
CONCLUSIONS AND CLINICAL RELEVANCE
Results indicated that relationships existed between ECG findings and 
cardiac morphology in the chimpanzees of the present study; however, 
further research is required to examine whether the predictive models 
generated can be modified to improve their clinical utility. (Am J Vet Res 
2020;81:488–498)
Cardiovascular disease has been suggested as the leading cause of death in captive populations of chimpanzees (Pan trog-
lodytes).1–4 Specifically, conditions such as arterial hypertension, 
ABBREVIATIONS
BM  Body mass
DCM  Dilated cardiomyopathy
LAAS Left atrial end-systolic area
LV  Left ventricle
LVH  Left ventricular hypertrophy
LVIDd  Left ventricular internal diameter in diastole
MLVWT  Mean left ventricular wall thickness
R2adj  Adjusted coefficient of determination
RAAS Right atrial end-systolic area
SLV15  Sokolow-Lyon voltage sum of the S-wave 
  amplitude in lead V1 + the greatest R-wave 
  amplitude in lead V5
SLV25  Sokolow-Lyon voltage sum of the S-wave 
  amplitude in lead V2 + the greatest R-wave 
  amplitude in lead V5
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congestive cardiac failure, and idiopathic myocardial 
fibrosis have been described.1,3,5–8 In humans, spe-
cific patterns of cardiac remodeling (eg, atrial and 
ventricular dilatation and hypertrophy) are often the 
hallmark of cardiac disease (eg, hypertrophic cardio-
myopathy, aortic stenosis, and congestive heart fail-
ure). Furthermore, adverse remodeling is related to 
an increased risk of cardiac events and poor progno-
sis in humans9,10 and other species.11–14 Importantly, 
however, cardiac remodeling in some conditions can 
be reversed with lifestyle adaptations and pharmaco-
logical agents, and such reversal is related to an im-
provement in overall prognosis.13–15 Accordingly, the 
ability to detect cardiac remodeling is important for 
the diagnosis and ongoing treatment of cardiac dis-
ease.
Although cardiac imaging (echocardiography 
and MRI) is the optimal method for detecting ad-
verse remodeling, this is not always possible, espe-
cially in species (eg, chimpanzees) being cared for 
in remote settings. Accordingly, the identification of 
other, more accessible diagnostic tools would be ben-
eficial. In a number of species, the relationship be-
tween the ECG results and measures of cardiac struc-
ture has been used to develop diagnostic criteria that 
are potentially indicative of adverse remodeling.16–21 
However, this relationship has not been examined in 
chimpanzees; thus, the clinical utility of ECG in this 
critically endangered species is limited. Exploring 
whether specific ECG characteristics relate to cardiac 
morphology in chimpanzees is the first step in po-
tentially developing useful diagnostic criteria. There-
fore, the initial aim of the study presented here was 
to use a large heterogeneous sample of chimpanzees 
to examine whether relationships existed between 
results for ECG variables and results for echocardio-
graphic measures of atrial areas, LV wall thicknesses, 
and chamber dimension, independent of body size. 
If relationships between results for ECG and echo-
cardiography were detected, then the secondary aim 
was to develop initial ECG prediction equations that 
might provide veterinary teams an initial screening 
tool to assess cardiac structure in chimpanzees.
Materials and Methods
Animals
Chimpanzees eligible for the study were those 
that underwent complete cardiac examinations dur-
ing routine health assessments between May 2011 
and July 2017 as part of the International Primate 
Heart Project and that were housed at any of 3 sanc-
tuaries for chimpanzees in Africa (the Tchimpounga 
Chimpanzee Rehabilitation Centre, Congo; Chimfun-
shi Wildlife Orphanage Trust, Zambia; and Tacugama 
Chimpanzee Sanctuary, Sierra Leone), 2 zoological 
parks in England (Chester Zoo and Zoological Soci-
ety of London Whipsnade Zoo), or 2 sanctuaries for 
chimpanzees in Europe (Welsh Ape and Monkey 
Sanctuary, England, and Animal Advocacy and Protec-
tion Rescue Centre for Exotic Animals, Netherlands). 
Animals were categorized according to whether they 
were ex-research chimpanzees, zoo-housed chim-
panzees, or African-sanctuary chimpanzees. Data for 
males versus females were also considered.
Health and cardiac assessments
All cardiac examinations were completed during 
preplanned health assessments, and as such, the cohort 
included was a convenience sample. All health assess-
ments were conducted at the housing facilities and by 
experienced veterinarians as previously described.22,23 
Briefly, once a chimpanzee was anesthetized and unre-
sponsive to external stimuli, the animal was weighed, 
then transported to an assessment area, where a full 
health assessment was completed. Each health assess-
ment included a thorough physical examination, blood 
sampling, morphometric measurements, and cardiac as-
sessment with 12-lead ECG and transthoracic echocar-
diography. Body weight was used as a surrogate for BM.
Anesthesia—Chimpanzees were anesthetized 
with 1 of 5 protocols: a combination of medetomi-
dine (0.03 to 0.05 mg/kg) and ketamine hydrochlo-
ride (3 to 5 mg/kg) administered IM by hand injection 
(MK), tiletamine-zolazepam (10 mg/kg) administered 
by remote dart injection (TZ), a combination of tilet-
amine-zolazepam (2 mg/kg) and medetomidine (0.03 
mg/kg) administered by remote dart injection (TZM), 
a combination of tiletamine-zolazepam (2 mg/kg) and 
ketamine (5 mg/kg) administered by remote dart in-
jection (TZK), or a combination of tiletamine-zolaze-
pam (2.5 to 3 mg/kg) and detomidine (40 to 50 µg/
kg) administered by remote dart injection (TZD). Fol-
lowing completion of health assessments on animals 
anesthetized with medetomidine or detomidine, ati-
pamezole (0.25 mg/kg, IM) was administered to re-
verse anesthesia.
ECGs—Chimpanzees were positioned in supine 
recumbency for the 12-lead ECG (with leads I, II, III, 
aVL, aVF, aVR, V1, V2, V3, V4, V5, and V6). Following 
skin preparation with an alcohol wipe, ECG lead elec-
trodes were placed as previously described24 and in 
line with human protocols.25 The ECGs were record-
ed with commercially available machinesa,b set at a 
paper speed of 25 mm/s and a gain of 10 mm/mV and 
were later analyzed by an experienced cardiac physi-
ologist (ALD). Findings from previous studies (eg, in 
humans,16,18,26–38,c dogs,39,40 cats,20,21,41 and rats42) that 
examined relationships between ECG results and car-
diac structure informed our selection of the specific 
ECG characteristics that we examined in relation to 
echocardiographic measures of cardiac structure in 
chimpanzees. Mean ± SD electrical axes of P waves, 
QRS complexes, and T waves were quantified. Dura-
tions of P waves, QRS complexes, R-R intervals, and 
QT intervals were measured in limb leads and pre-
cordial leads. In addition, because the QT interval is 
dependent on the heart rate, the Bazett formula43 was 
used to calculate a QT interval corrected for heart 
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rate. Voltage amplitudes of P, R, S, and Q waves and 
positive and negative deflections of ST segments and 
T waves were also measured in limb leads and precor-
dial leads. In addition, the Sokolow-Lyon criteria val-
ues were calculated44 as potential indicators of LVH,24 
with the sum of the voltage amplitudes of the S wave 
in V1 and the R wave in V5 for the SLV15, and with the 
sum of the voltage amplitudes of the S wave in V2 and 
the R wave in V5 for the SLV25.
Echocardiography—After undergoing ECG, chim-
panzees were positioned in left lateral recumbency 
for comprehensive transthoracic echocardiography, 
which was completed with a commercially available 
ultrasound machined and probese,f as previously de-
scribed23 and in line with human guidelines.25,45–47 
To minimize measurement variability inherent with 
composite echocardiographic measures and to not 
make any assumptions regarding cardiac geometry in 
chimpanzees, we chose to use measures of areas and 
dimensions, instead of measures of volume or mass. 
Atrial size was determined as the LAAS and RAAS mea-
sured in the apical 4-chamber view.45 The MLVWT was 
calculated as the mean of the LV septal and posterior 
wall thicknesses measured in the parasternal long-axis 
view.45 The LVIDd was adopted as a surrogate of LV 
size and was measured in the parasternal long-axis 
view.45 All echocardiographic images were analyzed 
with dedicated softwareg by an experienced echocar-
diographer (ALD), and all measurements were made in 
accordance with recommended guidelines.25,45,46
Scaling of echocardiographic variables
Because the aim was to assess whether relation-
ships exist between ECG results and echocardio-
graphic measures of cardiac size and wall thickness-
es, and because there is a strong relationship between 
cardiac size and body size, the echocardiographic 
measures were allometrically scaled to BM, for which 
body weight was used as a surrogate, to remove the 
influence of body size on the correlational and hier-
archical analysis.48,49 Body mass-scaling exponents 
were generated for each of the echocardiographic 
measures. These exponents were derived from the 
slope of the linear log-log plot of BM with each of the 
echocardiographic measures as recommended50 Fol-
lowing scaling, BM independence was assessed with 
Pearson correlation coefficient analysis between BM 
and each of the scaled echocardiographic variables. 
Results for the scaled echocardiographic variables 
were then correlated with the results for the ECG 
variables and entered into hierarchical regression.
Statistical analysis
To explore potential relationships between re-
sults for echocardiography and results for ECG, 
Pearson correlation coefficient (r) analysis was per-
formed. The α was set at 0.05, and the strength of the 
correlations were classified as negligible (r = 0.00 to 
0.30), low (r = 0.30 to 0.50), or moderate (r = 0.50 to 
0.70).50 When a significant correlation was identified, 
the specific ECG variables were entered into a regres-
sion model as independent variables in a hierarchical 
format (ie, highest to lowest R2adj). If an independent 
variable did not substantially improve the R2adj value 
(determined from the statistical significance of the 
summary F ratio), it was removed from the model. 
Selection of the optimal model was made with ref-
erence to the highest R2adj value with the lowest SE 
of the estimate. Linearity and homoscedasticity were 
confirmed through observation of scatterplots from 
the relevant results. The independence of residuals 
was assessed with the Durbin-Watson statistic, and 
multicollinearity was assessed with tolerance values. 
Outliers were examined with Cook distance and le-
verage points for influence over the model, and indi-
vidual studentized residuals with Cook distance > 1 
and leverage points > 0.2 were deleted.51
To more fully explore relationships between 
results for ECG and results for echocardiography, a 
diverse sample of chimpanzees was purposely includ-
ed. To better characterize the overall sample popula-
tion, 1-way ANCOVA with Bonferroni post hoc analy-
sis was used to examine differences in results by age, 
BM, and crown-to-rump length for the 3 categories 
of animals (ie, ex-research chimpanzees, zoo-housed 
chimpanzees, and African-sanctuary chimpanzees). 
However, we purposely chose not to include the cap-
tive environment variable in our models because our 
primary aim was to explore the potential for ECG 
variables to be used as predictors of cardiac struc-
ture, not to examine the influence of environment on 
cardiac phenotype. All statistical analyses were con-
ducted with dedicated software.h
  Presentation of predictive models—Predictive models 
were presented in the form:
Y = a + b1X1 + b2X2 + b3X3 + … + bkXk + e
where a is the intercept on the y-axis of an X-Y scat-
terplot, b is the β component (regression coefficient 
for a given independent variable), and e is the SE of 
the estimate, which estimated the proportion of the 
variance in the Y variable (dependent variable) un-
explained by the model. Each of the regression co-
efficients (β components) estimated the amount of 
change that occurred in the dependent variable for 
a 1-unit change in the related independent variable, 
with the effect of all other independent variables in 
the equation controlled. Each model had a different 
level of e in the prediction of the echocardiographic 
variable. The model output ± (e X 1.96) provided the 
95% CI of prediction for each model.
Results
Animals
Between May 2011 and July 2017, the International 
Primate Heart Project completed cardiac examinations 
of 341 chimpanzees (175 males and 166 females) dur-
ing routine health assessments (Table 1). Of these 341 
chimpanzees, 34 were ex-research chimpanzees (18 
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males and 16 females), 20 were zoo-housed chimpan-
zees (9 males and 11 females), and 287 were African-
sanctuary chimpanzees (148 males and 139 females). 
The sample heterogeneity, with wide ranges in ages 
(range, 1 to 55 years), BM (range, 4 to 81 kg), and crown-
to-rump lengths (range, 28 to 89 cm), made the chim-
panzees of the study an ideal cohort to initially explore 
the relationships of interest. Mean ± SD BM was greater 
in zoo-housed chimpanzees (61 ± 8 kg for males and 
59 ± 10 kg for females) and ex-research chimpanzees 
(56 ± 9 kg for males and 57 ± 5 kg for females) than in 
African-sanctuary chimpanzees (42 ± 16 kg for males 
and 37 ± 11 kg for females). Subjectively, zoo-housed 
and ex-research chimpanzees also appeared to have 
had greater subcutaneous fat than did African-sanctuary 
chimpanzees.
Cardiac variables
For examinations, chimpanzees underwent gen-
eral anesthesia achieved with 1 of 5 protocols: MK (n 
= 184; 92 males and 92 females), TZ (29; 14 males and 
15 females), TZM (67; 40 males and 27 females), TZK 
(27; 11 males and 16 females), and TZD (34; 18 males 
and 16 females). Electrocardiographic and echocar-
diographic results were compiled (Tables 2 and 3). 
Overall, there were wide ranges in results for ECG 
and echocardiography. Mean ± SD heart rate, P-wave 
duration and amplitude, and QRS-complex duration 
were 70 ± 31 beats/min, 97.1 ± 42.6 milliseconds, 0.1 
± 0.1 mV, and 83.5 ± 38.2 milliseconds, respectively. 
Mean ± SD LAAS, RAAS, MLVWT, and LVIDd were 16 
± 5 cm2, 9 ± 3 cm2, 0.70 ± 0.20 cm, and 4.2 ± 0.7 cm, 
respectively. Although most (314/341 [92.1%]) chim-
panzees did not have overt cardiac remodeling, echo-
cardiography revealed abnormal cardiac morphology, 
including suspected LVH (n = 15), dilated LV (6), and 
dilated atria (9). Of note, 1 chimpanzee had extreme 
LVH (MLVWT, 1.62 cm; reference range, 0.55 to 1.1 
cm23) on echocardiography and an SLV25 of 5.5 mV 
(reference range, 1.7 to 5.8 mV24).
Echocardiographic variables scaled  
for BM
Body mass–scaling exponents were derived from 
the slope of the linear log-log plot of BM with each 
of the echocardiographic variables. Resultant expo-
Table 1—Summary demographic and morphometric data for 341 chimpanzees (Pan troglodytes), stratified by population category (African-sanctu-
ary chimpanzees, ex-research chimpanzees, or zoo-housed chimpanzees) and sex (male or female), that underwent general anesthesia for routine 
health examinations, 12-lead ECG, and echocardiography between May 2011 and July 2017 as part of the International Primate Heart Project.
 African-sanctuary Ex-research Zoo-housed 
 chimpanzees chimpanzees chimpanzees All chimpanzees
 Males Females  Males Females Males Females 
 (n = 148) (n = 139) (n = 18) (n = 16) (n = 9) (n = 11) (n = 341)
Variable Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range
Age (y) 14 ± 8 1–37 15 ± 7 1–38 32 ± 9* 16–55 32 ± 9* 21–52 31 ± 15† 9–51 29 ± 9* 17–42 17 ± 10 1–5
BM (kg) 42 ± 16 4–75 37 ± 11 4–65 56 ± 9* 43–73 57 ± 5* 49–64 61 ± 8* 42–70 59 ± 10* 45–81 42 ± 15 4–81
Crown-to-rump 64 ± 11 28–89 63 ± 9 30–86 77 ± 5* 71–85 76 ± 6* 65–87 81 ± 3*ǂ 76–84 68 ± 5ǂ 63–79 66 ± 10 28–89
  length (cm)
*Results differed significantly (P < 0.001) from those of African-sanctuary chimpanzees. †Results differed significantly (P < 0.05) from those of African-sanctuary chimpanzees. 
Table 2—Summary of the key results from 12-lead ECG 
(with leads I, II, III, aVL, aVF, aVR, V1, V2, V3, V4, V5, and V6) 
assessments of the chimpanzees described in Table 1.
Variable Mean ± SD         Range
Heart rate (beats/min) 70 ± 31 41 to 101
Waveform mean
  electrical axes (°)  
  P 57.0 ± 27.9 –49 to 133
  QRS 52.7 ± 26.7 –90 to 94
  T 40.7 ± 26.5 –126 to 90
Waveform durations (ms)  
 R-R interval 877.1 ± 397.6 87 to 1,472
 P 97.1 ± 42.6 58 to 200
 QRS 83.5 ± 38.2 52 to 230
 QT 387.1 ± 170.8 280 to 544
 QTc 408.3 ± 180.3 39 to 534
Waveform amplitudes (mV)  
 PII 0.10 ± 0.10 –0.07 to 0.25
 RII 1.10 ± 0.50 0.03 to 2.96
 SII –0.10 ± 0.10 –0.58 to 0.40
 STII 0.10 ± 0.50 –0.11 to 10
 T POSII 0.20 ± 0.10 –0.35 to 0.72
 T NEGII 0.0 ± 0.0 –0.16 to 0.18
   
 T POSIII 0.1 ± 0.1 –0.17 to 0.41
 T NEGIII 0.0 ± 0.0 –0.15 to 0.42
   
 R aVL 0.24 ± 0.14 0.01 to 1.07
 R aVF 0.94 ± 0.52 0.03 to 2.6
 T POS aVF 0.15 ± 0.13 –0.32 to 0.62
 T NEG aVF 0.02 ± 0.03 –0.16 to 0.29
   
 S V1 –1.10 ± 0.61 –2.9 to 1.1
 S V2 –1.09 ± 0.61 –3 to 1.2
 S V3 –0.76 ± 0.46 –3.59 to 0.3
   
 R V5 1.73 ± 0.78 0.03 to 4.61
 ST V5 0.10 ± 0.06 –0.04 to 0.31
 T POS V5 0.32 ± 0.24 –0.26 to 1.41
 T NEG V5 0.02 ± 0.02 –0.06 to 0.13
   
 R V6 0.97 ± 0.40 0.03 to 2.7
 ST V6 0.04 ± 0.04 –0.47 to 0.3
 T POS V6 0.19 ± 0.11 –0.25 to 0.6
 T NEG V6 0.01 ± 0.01 –0.06 to 0.17
Sokolow-Lyon criteria (mV)  
 SLV15 3.03 ± 1.10 0.95 to 6.81
 SLV25 3.01 ± 1.10 0.76 to 7.1
P = P wave. QRS = QRS complex. QT = QT interval. QTc = 
QT interval corrected (with the Bazett formula43) for heart rate. 
R = R wave. S = S wave. ST = ST segment. T = T wave. T NEG = 
Negative deflection of the T wave. T POS = Positive deflection of 
the T wave. 
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nents were LAAS/BM0.612, RAAS/BM0.591, MLVWT/
BM0.451, and LVIDd/BM0.3224. Independence of BM was 
then confirmed with the findings of nonsignificant 
correlations (Pearson correlation coefficient analysis) 
between each of the scaled echocardiographic vari-
ables and BM.
Correlational analysis
Results of Pearson correlations coefficient (r) 
analysis between findings for ECG variables and 
echocardiographic variables (ie, RAAS, LAAS, 
MLVWT, and LVIDd) scaled for BM were compiled 
(Table 4). Results for P-wave duration and ampli-
tude in lead II significantly (P < 0.05) correlated 
with results for LAAS and RAAS scaled for BM. In 
addition, results for several ECG variables signifi-
cantly (P < 0.05) correlated with MLVWT scaled 
for BM, with the strongest relationships detected 
between it and SLV15 (r = 0.308), SLV25 (r = 0.310), 
QRS-complex duration (r = 0.229), and R-wave am-
plitude in leads V5, V6, and II (r = 0.246, r = 0.229, 
and r = 0.205, respectively). Similarly, significant (P 
< 0.05) correlations were also identified between 
results for LVIDd scaled for BM and results for ECG 
variables, including SLV15 (r = 0.216), SLV25 (r = 
0.226), QRS-complex duration (r = 0.243), QT in-
terval (r = 0.205), and S-wave amplitude in leads V1, 
V2, and V3 (r = –0.223, r = –0.231, and r = –0.231, 
respectively).
Predictive models
Through hierarchical regression, predictive mod-
els for RAAS, LAAS, MLVWT, and LVIDd scaled for BM 
were developed. These predictive models accounted 
for 17%, 7%, 11%, and 8% of the variance in RAAS, 
LAAS, MLVWT, and LVIDd, respectively (Figure 1; 
Table 5). Because a number of different anesthetic 
protocols were used, the influence of anesthetic pro-
tocols on the models was explored. However, inclu-
sion of anesthetic protocols into the models did not 
meaningfully improve the R2adj; thus, anesthetic pro-
tocols were not included in the final models. There 
was no evidence of multicollinearity, as assessed by 
tolerance values, and there were no individual stu-
dentized deleted residuals with Cook distance > 1 
and leverage points > 0.2 in any of the models.
Discussion
The initial aim of the present study was to ex-
amine whether relationships exist between the ECG 
and echocardiographic measures of RAAS, LAAS, 
MLVWT, or LVIDd in chimpanzees, independent of 
body size. The second aim was to examine whether 
ECG models could be constructed that predict cardi-
Table 3—Summary echocardiographic results for LAAS, RAAS, MLVWT, and LVIDd in the chimpanzees described in Table 1, 
stratified by population category and sex.
 African-sanctuary chimpanzees Ex-research chimpanzees Zoo-housed chimpanzees All chimpanzees
 Males (n = 148)  Females (n = 139) Males (n = 18)  Females (n = 16) Males (n = 9) Females (n = 11) (n = 341) 
Variable Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range
LAAS (cm2) 16 ± 5 4–28 15 ± 3 4–23 23 ± 3 19–30 20 ± 3 16–24 19 ± 6 14–32 19 ± 6 14–32 16 ± 5 4–32
RAAS (cm2) 9 ± 3 3–19 8 ± 2 3–14 14 ± 3 10–22 11 ± 1 8–13 10 ± 3 6–18 12 ± 5 6–25 9 ± 3 2–25
MLVWT (cm) 0.71 ± 0.19 0.30–1.62 0.60 ± 0.12 0.30–0.90 1.00 ± 0.19 0.60–1.40 0.89 ± 0.24 0.40–1.30 0.92 ± 0.24 0.60–1.35 0.79 ± 0.12 0.65–1.00 0.70 ± 0.20 0.30–1.62
LVIDd (cm) 4.3 ± 0.8 2.1–7.0 3.9 ± 0.5 1.8–4.9 4.9 ± 0.4 4.3–5.9 4.3 ± 0.4 3.4–4.8 4.7 ± 0.8 3.8–6.1 4.6 ± 0.5 4.0–5.6 4.2 ± 0.7 1.8–7.0
Table 4—Results of Pearson correlation coefficient (r) analy-
sis between results for echocardiographic variables (LAAS, 
RAAS, MLVWT, and LVIDd) scaled for BM and results for ECG 
variables described in Table 2 for the chimpanzees described 
in Table 1.
 BM-scaled echocardiographic variables
 LAAS RAAS MLVWT LVID
ECG variable (r) (r) (r) (r)
Waveform mean electrical axes
 P 0.142* 0.830 —     —
 QRS 0.023 –0.013 0.190 0.108*
 T –0.048 0.953 –0.088 0.074
Waveform durations    
 P 0.235† 0.176† —     —
 QRS —  —  0.229† 0.243†
 QT 0.050 0.039 0.016 0.205†
 QTc 0.093 –0.049 0.066 –0.089
Waveform amplitudes    
 PII 0.201† 0.176†  —    —
 RII — — 0.205† 0.090
 SII — —  
 STII — — 0.050 –0.009
 T POSII — — –0.097 –0.099
 T NEGII — — 0.051 –0.028
     
 T POSIII — — –0.121* –0.064
 T NEGIII — — 0.028 –0.003
     
 R aVL — — 0.050 0.115*
 R aVF — — 0.198† 0.137†
 T POS aVF — — –0.095 –0.024
 T NEG aVF — — 0.051 –0.005
     
 S V1 — — –0.217* –0.223†
 S V2 — — –0.231* –0.231†
 S V3 — — –0.233* –0.231†
     
 R V5 — — 0.246† 0.175*
 ST V5 — — 0.109* –0.020
 T POS V5 — — 0.090 –0.043
 T NEG V5 — — 0.080 –0.058
     
 R V6 — — 0.229† 0.134†
 ST V6 — — 0.060 –0.055
 T POS V6 — — –0.098 –0.107
 T NEG V6 — — –0.020 –0.072
Sokolow-Lyon criteria (mV)    
 SLV15 — — 0.308† 0.261†
 SLV25 — — 0.310† 0.266†
*P < 0.05. †P < 0.001.
 — = Not assessed.
See Table 2 for remainder of the key.
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ac structure and hence help the assessment of cardi-
ac remodeling in chimpanzees. Our primary finding 
was that relationships, albeit weak, existed between 
results for multiple ECG variables and echocardio-
graphic measures of cardiac structure in the chim-
panzees of the present study. The predictive models 
we generated accounted for 17%, 7%, 11%, and 8% of 
the variance in RAAS, LAAS, MLVWT, and LVIDd, re-
spectively. Although our findings indicated that ECG 
results were related to cardiac structure in chimpan-
BM-scaled 
echocardiographic
variables   R2adj a ECG variables β	 e SE of β	 95% CI of β
LAAS (cm2) 0.067 1.239 P-wave duration 0.004 0.27 0.001 0.001–0.006
   P-wave amplitude 0.874  0.338 0.209–1.539
     in lead II
RAAS (cm2) 0.173 1.303 P-wave duration 0.807 2.91 0.072 0.667–0.948
MLVWT (cm) 0.115 0.109 SLV25 0.006 0.02 0.001 0.003–0.008
   QRS-complex duration 0.001  0.001 0.001–0.002
LVIDd (cm) 0.080 1.087 SLV25 0.022 0.11 0.006 0.010–0.033
   QRS-complex duration 0.001  0.000 0.001–0.002
a = The intercept on the y-axis. β = Regression coefficient. e = SE of the estimate.
Table 5—Results of hierarchical regression analysis to generate ECG predictive models for RAAS, LAAS, MLVWT, and LVIDd 
scaled to BM in the chimpanzees described in Table 1.
Figure 1 continues on the next page
494 AJVR • Vol 81 • No. 6 • June 2020
zees, it appeared that these ECG models cannot be 
used to accurately predict cardiac chamber sizes and 
wall thicknesses.
Our results indicated that P-wave duration and 
amplitude in lead II weakly correlated with end 
systolic atrial areas in chimpanzees. As the P wave 
reflects atrial depolarization, the finding that P-
wave duration and amplitude were related to atrial 
areas in chimpanzees of the present study was un-
surprising. It is rational that in animals with larger 
atria, the electrical propagation across the myocar-
dium will take longer and have a greater amplitude. 
In humans16,21,34,52 and cats,20,53 P-wave amplitude, 
duration, axis, and morphology and PR interval 
have all been shown to be related to adverse atrial 
remodeling, with P-wave amplitude showing the 
strongest relationship.26,32,36 Yet, in the chimpan-
zees of the present study, P-wave duration had a 
stronger relationship with atrial areas than did P-
wave amplitude. Moreover, P-wave axis and mor-
phology were not strongly related to atrial areas 
in the present cohort. It has been reported24 that 
chimpanzees have small P-wave amplitudes, com-
pared with other ECG waveforms, and this could 
have explained the weaker correlation between 
P-wave amplitude and atrial areas in the present 
study. The cause of small P waves in chimpanzees 
is unknown but may reflect a different diastolic 
filling pattern in chimpanzees. Compared with 
humans, it appears that the atrial contribution to 
ventricular filling is relatively modest in chimpan-
zees.23 As such, the atria might function more as 
a conduit rather than an active pump, and so the 
atrial myocardial mass and resulting P-wave ampli-
tudes could be smaller in chimpanzees.
Findings from the present study suggested that 
the Sokolow-Lyon criteria; amplitudes of the R waves 
in leads II, aVF, V5, and V6; amplitudes of the S waves 
in leads V1, V2, and V3; QRS-complex duration; posi-
tive deflection of the T wave in lead III; and ST am-
plitude in lead V5 are all related to MLVWT in chim-
panzees. It is logical that electrical amplitude and 
Figure 1—Scatterplots of results for ECG variables (P-wave amplitude [A and C] and duration [B and D] in lead II, QRS-
complex duration [E and G], and SLV25 [F and H]) versus results for BM-scaled echocardiographic variables (RAAS [A and 
B], LAAS [C and D], MLVWT [E and F], and LVIDd [G and H]) for 341 chimpanzees (Pan troglodytes) that underwent general 
anesthesia for routine health examinations, 12-lead ECG, and echocardiography between May 2011 and July 2017 as part of the 
International Primate Heart Project. In each panel, the solid line represents the regression line, dotted lines represent the 95% 
CI limits of the regression line, and circles represent results for individual chimpanzees.
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duration will increase as cardiac wall thicknesses 
increase, and our findings that the amplitudes of R 
and S waves weakly correlated with LV wall thick-
nesses in chimpanzees were similar to findings in hu-
mans,21,44,54 cats,41 and rats42 in which voltage criteria 
are the most specific and sensitive for detecting LVH. 
However, there appeared to have been some chim-
panzees in our study with thicker LV walls but with-
out markedly large amplitudes of R and S waves. This 
finding could have indicated LV wall thickening from 
diffuse idiopathic myocardial fibrosis, as evidenced 
in other chimpanzee cohorts.6,7,55 From our data, we 
did not know whether these thicker LV wall measure-
ments reflected electrically active myocardium. For 
example, in humans with cardiac amyloidosis, de-
spite LVH, QRS-complex amplitudes are low because 
the hypertrophy is caused by infiltration of electri-
cally inactive tissue.56 If some animals in our cohort 
did indeed have idiopathic fibrosis, this could have 
resulted in larger MLVWTs but not a concomitant in-
crease in QRS-complex amplitudes.
In the chimpanzees of the present study, nu-
merous ECG variables (including durations of QRS 
complexes and QT intervals; amplitudes of R waves 
in leads aVL, aVF, V5, and V6 ; and amplitudes of 
S waves in leads V1, V2, and V3) were related to 
LVIDd, and the Sokolow-Lyon criteria, QRS-complex 
duration, and R- and S-wave amplitudes had the 
strongest correlations. These findings were again 
similar to those in humans whereby amplitudes of 
R and S waves, duration of QRS complexes, and ab-
normalities of ST segments, T waves, and Q waves 
relate to increased ventricular chamber size.38,c Cau-
tion is needed when directly comparing findings of 
the present report with those in human medicine 
because ECG variables have been identified in hu-
mans with marked cardiac disease, such as DCM and 
LV dilatation related to valve disease.38,c Because the 
underlying causes of these conditions are different, 
the myocardial properties with each will result in 
specific disease-related ECG patterns. For example, 
histologic findings in DCM demonstrate a reduction 
in myocardial fiber mass with concomitant fiber elon-
gation and hypertrophy, resulting in ECG findings of 
greater precordial QRS-complex amplitudes.57 Yet, 
in end-stage DCM, amplitudes of QRS complexes 
are low because of replacement fibrosis.58 Under-
standing the properties of the myocardium is there-
fore important for interpreting ECG alterations in 
various diseases. As noted previously, although we 
know that some chimpanzees in other populations 
have shown evidence of idiopathic myocardial fibro-
sis and appeared to have had a higher proportion of 
collagen in the myocardium, compared with that in 
humans,4 the properties of the myocardium in the 
chimpanzees of the present study was not known. 
Accordingly, follow-up postmortem work would be 
required to ascertain any underlying cardiac disease 
and examine whether this may have impacted any 
of the relationships we assessed.
Although our findings indicated that a number 
of ECG variables correlated with echocardiographic 
measures of atrial and ventricular structure, the ECG 
predictive models, for the most part, only accounted 
for a small to modest amount of the variance (7% to 
17%). Of the 4 predictive ECG models generated, the 
strongest was for predicting RAAS, which account-
ed for 17% of the variance. Putting this finding into 
context with existing human literature was chal-
lenging because most studies16,31,32,34–36,44,c explored 
the sensitivity and specificity of various ECG criteria 
in relation to a known diagnostic threshold or clini-
cal end point, not relationships between results for 
ECG versus echocardiography. At present, diagnostic 
thresholds related to cardiac structure have yet to 
be established in chimpanzees; thus, it was not pos-
sible to explore the sensitivity or specificity of ECG 
characteristics in the present study. However, the 
low amount of variance accounted for by the models 
in the present study could have suggested that, as in 
humans,27 ECG variables do not provide definitive in-
formation regarding cardiac chamber sizes and wall 
thicknesses in chimpanzees. In contrast, a study20 of 
cats shows that ECG findings have some clinical util-
ity in the diagnosis of LVH.
A major limitation of the present study was the 
lack of substantial cardiac diseases in our cohort. His-
torically, ECG criteria for detecting cardiac remod-
eling in humans16–19,21,38 and animals (eg, cats,11,12,20 
dogs,38,39 and rats42) have been based on research 
from large samples of abnormal and normal cardiac 
phenotypes. Although there was a range in cardiac 
morphology in chimpanzees of the present study, 
most animals did not have overt remodeling. None-
theless, 1 chimpanzee had extreme LVH (MLVWT = 
1.62 cm) identified with echocardiography and also 
had an SLV25 of 5.5 mV, which suggested that in chim-
panzees with severe LVH, there may be a strong cou-
pling of ECG results with the cardiac structural phe-
notype. Further work in a more diverse population 
of chimpanzees, including those with heart disease, 
would be required to confirm such a relationship. Be-
yond this, once clinical definitions of the clinically 
normal cardiac phenotype and specific cardiac dis-
eases have been established in chimpanzees, it will 
be possible to explore the sensitivity and specificity 
of the ECG characteristics to identify adverse cardiac 
remodeling.
It is important to note that in humans and oth-
er animals, there is evidence that ECG results can 
be influenced by changes to body position, elec-
trode placement, and body habitus.59–61 In the pres-
ent study, human guidelines were followed for pa-
tient positioning and electrode placement, and we 
recognized that these may not have been optimal 
for chimpanzees. Furthermore, body habitus influ-
ences durations and amplitudes of ECG waveforms 
in humans and other species.62–64 In the present 
study, zoo-housed and ex-research chimpanzees 
had greater BM and subjectively more subcutaneous 
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fat than did the African-sanctuary chimpanzees. Al-
though echocardiographic data were scaled to BM, 
this did not account for the influence of body fat 
percentage or, more specifically, the location of fat, 
which could have resulted in lower amplitudes for 
QRS complexes in the larger chimpanzees despite 
the presence of greater MLVWT in these animals. 
Therefore, as has been done in cats59 and dogs,60 fu-
ture work should investigate the influence of ECG 
electrode placement and body habitus on the re-
lationship between results for ECG versus cardiac 
morphology in chimpanzees.
In addition to the influence of body habitus on 
ECG voltages, body size is known to have a strong 
curvilinear relationship with cardiac size in a num-
ber of species.49,65 Therefore, in the present study, 
cardiac chamber sizes and wall thickness were allo-
metrically scaled to BM in an attempt to create body 
size–independent measures of cardiac structure. 
However, current scaling recommendations sug-
gest lean BM and fat-free mass are likely the optimal 
body size scalar variables because they represent 
metabolically active tissue. The use of BM as a scalar 
variable, as in the present study, can be problem-
atic, particularly if the proportions of muscle mass 
and adipose fat are not consistent across the sample 
studied.48,66 It was possible that scaling to  BM in our 
study may have resulted in an overcorrection of car-
diac dimensions in overweight chimpanzees67 from 
the zoo-housed and ex-research groups. Future work 
is needed to understand the relationships between 
body composition, cardiac size, and ECG results to 
generate an appropriate chimpanzee-specific body 
size scalar variable. If such an appropriate scalar 
variable can be generated, this in turn may improve 
the strength of the predictive models generated in 
the present study.
It is important that we acknowledge that all chim-
panzees were anesthetized so that the routine health 
assessments could be completed safely, and we rec-
ognize that although the inclusion of anesthesia did 
not significantly improve the R2adj of the predictive 
models, anesthesia may have influenced our findings. 
Moreover, anesthetic agents could have contributed 
to some of the differences between ECG results of the 
present study, compared with other species, because, 
for instance, humans, cats, and dogs are not gener-
ally anesthetized for ECG. It has been suggested that 
general anesthesia influences cardiac rhythm and the 
durations of the ST-T segment, QT interval, and QT in-
terval corrected for heart rate68–70; however, without 
knowing the direct impact of the various anesthetic 
protocols on the ECG results for the chimpanzees in 
the present study, it was impossible to speculate on 
this issue further.
Results of the present study were the first to indi-
cate that relationships, albeit weak, existed between 
ECG findings and cardiac morphology in chimpan-
zees. However, the use of ECG to predict cardiac 
structure appears limited, and further work is need-
ed to improve predictive ECG models and their clini-
cal utility in chimpanzees.
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